Specific forms of synaptic plasticity such as long-term potentiation (LTP) are modulated by or require increases in cAMP. The various adenylyl cyclase isoforms possess unique regulatory properties, and thus cAMP increases in a given cell type or tissue in response to converging signals are subject to the properties of the adenylyl cyclase isoforms expressed. In most tissues, adenylyl cyclase activity is stimulated by neurotransmitters or hormones via stimulatory G-protein (G s )-coupled receptors and is inhibited via inhibitory G-protein (G i )-linked receptors. However, in the hippocampus, stimulation of G icoupled receptors potentiates G s -stimulated cAMP levels. This effect may be associated with the regulatory properties of adenylyl cyclase types 2 and 4 (AC2 and AC4), isoforms that are potentiated by the ␤␥ subunit of G i in vitro. Although AC2 has been shown to be stimulated by ␤␥ in whole cells, reports describing the sensitivity of AC4 to ␤␥ in vivo have yet to emerge. Our results demonstrate that G s -mediated stimulation of AC4 is potentiated by ␤␥ released from activated G i -coupled receptors in intact human embryonic kidney (HEK) 293 cells. Furthermore, we show that the AC2 and AC4 proteins are expressed in the mouse hippocampal formation and that they colocalize with MAP2, a dendritic and/or postsynaptic marker. The presence of AC2 and AC4 in the hippocampus and the ability of each of these enzymes to detect coincident activation of G s -and G i -coupled receptors suggest that they may play a crucial role in certain forms of synaptic plasticity by coordinating such overlapping synaptic inputs.
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The regulation of adenylyl cyclases by G-protein-coupled receptors is a classically described mechanism in which a stimulatory G-protein (G s ) couples neurotransmitters to activation of adenylyl cyclase, whereas an inhibitory G-protein (G i ) couples to inhibition of adenylyl cyclase. In certain tissues, G i signaling can potentiate G s input (Andrade, 1993; Gereau and Conn, 1994; Pian and Dobbs, 1995; Olianas et al., 1998) . Specifically, norepinephrine-or isoproterenol-induced increases in cAMP are enhanced by activation of G i -coupled 5-HT 1A or GABA B receptors (Andrade, 1993) .
Although the C a 2ϩ -stimulated adenylyl cyclases (AC1 and AC8) are believed to play a role in synaptic plasticity in the hippocampus (Choi et al., 1993; Weisskopf et al., 1994; Wu et al., 1995; X ia et al., 1995; Villacres et al., 1998) , other isoforms may also be necessary. For example, at the mossy fiber (mf)-CA3 synapse, long-term potentiation (LTP) is dependent on opioid neurotransmission (Williams and Johnston, 1996) . Opioid receptors are coupled to G i /G o , and pertussis toxin treatment prevents the development of LTP at this synapse (Ito et al., 1988) . In addition, elevation of cAM P is required for mf-CA3 LTP (Huang et al., 1994 (Huang et al., , 1995 Weisskopf et al., 1994) as well as for long-lasting LTP in area CA1 (Frey et al., 1993) . Pertussis toxin treatment has also been demonstrated to prevent the formation of LTP in area CA1 Pennefather, 1989, 1990) .
To date, nine mammalian adenylyl cyclase isotypes (AC1-AC9) have been identified (Krupinski et al., 1989; Bakalyar and Reed, 1990; Feinstein et al., 1991; Gao and Gilman, 1991; Ishikawa et al., 1992; Katsushika et al., 1992; Premont et al., 1992 Premont et al., , 1996 Yoshimura and Cooper, 1992; Cali et al., 1994; Hellevuo et al., 1995) . Each is distributed and regulated uniquely (Choi et al., 1993; Iyengar, 1993; Cooper et al., 1995; Taussig and Gilman, 1995; Xia et al., 1995; Sunahara et al., 1996) . mRNA has been detected for AC1 (Xia et al., 1991) , AC2 (Furuyama et al., 1993) , AC3 (Glatt and Snyder, 1993) , AC8 (Cali et al., 1994) , and AC9 (Premont et al., 1996) in the mammalian hippocampus.
The in vitro regulatory properties of AC2 and AC4 are consistent with the possibility of a role in G i -mediated potentiation of G s -stimulated cAMP. The activity of both isoforms is potentiated in vitro by G i in the presence of G s (Feinstein et al., 1991; Gao and Gilman, 1991; Lustig et al., 1993) . Whereas AC2 has been characterized extensively in intact cells (Federman et al., 1992; Jacobowitz et al., 1993; Lustig et al., 1993; Tsu and Wong, 1996) , in vivo regulatory properties of AC4 have not been defined. Furthermore, it is not known whether either of the ␤␥-stimulated adenylyl cyclase proteins is expressed in the hippocampus. To assess whether AC2 and/or AC4 could be involved in the control of hippocampal cAMP levels, we determined the immunohistochemical localization of AC2 and AC4 proteins in the mouse hippocampus and characterized the regulation of AC4 in human embryonic kidney (HEK) 293 cells. Our findings suggest that the presence of AC2 and/or AC4 in the hippocampus may account for some of the electrophysiological and biochemical effects of coincident G s -and G i -coupled receptor activation (Andrade, 1993; Gereau and Conn, 1994) .
MATERIALS AND METHODS
Materials. Isoproterenol, 3-methyl-1-isobutylxanthine (I BMX), serotonin, and somatostatin-14 were purchased from Sigma (St. L ouis, MO). Pertussis toxin was obtained from List Biologic (C ampbell, CA). Restriction endonucleases and DNA ligase were purchased from New England Biolabs (Beverly, M A). Polyclonal antibodies generated against adenylyl cyclases 2 or 4 were generously provided by Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal antibodies generated against M AP-2 or synaptophysin were purchased from Sigma.
Cell culture. H EK 293 cells were grown at 37°C in H EPES-buffered (H)-DM EM supplemented with 10% bovine calf serum (BC S) and 1% penicillin and streptomycin in a humidified 95% O 2 /5% C O 2 incubator. C ell culture materials were obtained from Life Technologies (Gaithersburg, MD) unless otherwise indicated.
E xpression of the 5-HT 7A receptor and AC2 or AC4 in HEK 293 cells. The AC4 cDNA clone was generously provided by Drs. Wei-Jen Tang and Alfred G. Gilman (University of Texas Southwestern Medical C enter, Dallas, TX). The AC4 insert was released from pBluescript (Stratagene, La Jolla, CA) by digestion with KpnI and BamHI and was ligated into the pCEP4 expression vector (Invitrogen, San Diego, CA). The AC2 cDNA was generously provided by Dr. Randall R. Reed (Johns Hopkins School of Medicine, Baltimore, MD) and was ligated into pCEP4. The 5-HT 7A receptor cDNA clone was a gift from Dr. Mark Hamblin (Veterans Administration Medical C enter, Seattle, WA) and was ligated into pcDNAIII (Invitrogen). Polyclonal populations of G418-(500 g /ml; C albiochem, La Jolla, CA) and /or hygromycin-(400 g /ml; C albiochem) resistant 293 cells were obtained by stable transfection of the pcDNAIII or pCEP4 expression vector and /or pcDNAIII-5-HT 7A or pCEP4-AC4 (or pCEP4-AC2 alone for analysis of AC2 expression by immunocytochemistry) using the calcium phosphate method (Chen and Okayama, 1987) . All stable cell lines were created from the same parental population of H EK 293 cells. E xpression of 5-HT 7A or exogenous adenylyl cyclases was determined by cAM P accumulation assays as described below.
cA MP accumulation assay. Changes in intracellular cAM P were measured by determining the ratio of [ 3 H]cAM P to the total ATP, ADP, and AM P pool in [ 3 H]adenine-loaded cells as described previously (Wong et al., 1991) . This assay system allows for rapid and sensitive determination of relative changes in intracellular cAM P. Although the ratios measured between assays generally vary somewhat, the relative change in cAM P observed between assays is very reproducible. In brief, as cells in 12-well plates approached confluency, they were incubated in H-DM EM plus 10% BC S containing 2 Ci of [ 3 H]adenine (IC N Biochemicals, Costa Mesa, CA) per well for 16 -20 hr. The next day, the labeling medium was aspirated, and the cells were washed once with 150 mM NaC l and incubated in H-DM EM plus 1% penicillin and streptomycin containing the indicated effectors (e.g., isoproterenol, serotonin, and somatostatin) plus 1 mM I BMX for 30 min. Reactions were terminated by aspiration of the medium and addition of 1 ml of ice-cold 5% trichloroacetic acid plus 1 M cAM P. Culture dishes were maintained at 4°C for 1-4 hr, and acid-soluble nucleotides were separated by sequential Dowex AG50W X-4 and neutral alumina chromatography as described previously (Salomon et al., 1974) . The data are reported as the average of triplicate determinations. Pertussis toxin, when used, was added to cells during the [ 3 H]adenine-labeling period for 16 -20 hr. Transient coe xpression of AC4 with the C terminal of ␤-adrenerg ic receptor k inase 1 or transducin ␣ in HEK 293 cells. The peptide minigene construct encoding the C terminal of ␤-adrenergic receptor kinase 1 (␤ARK 1 -ct, denoted the "PH domain" for pleckstrin homology domain) in the pRK5 plasmid was generously provided by Dr. Robert Lefkowitz (Duke University Medical C enter, Durham, NC). A cDNA clone for the ␣ subunit of human rod transducin (denoted G t ) was provided by Dr. Neil M. Nathanson (University of Washington, Seattle, WA). Briefly, the night before transfection, cells were plated onto 100 mm plates at a density of ϳ70%. The following morning, each plate was transfected with 8 g of total DNA [1 g of 5-HT 7A , 2.5 g of pCEP4 or pCEP4-AC4, 4 g of pCDNAIII, pCDNAIII-transducin ␣, or pRK-␤ARK 1 -ct, and 0.5 g of Rous sarcoma virus (RSV)-␤-galactosidase] in H-DM EM in the presence of 50 -60 l of Lipofectamine (Life Technologies). After 5 hr, cells were rinsed with H-DM EM plus 1% penicillin and streptomycin and 10% BC S and were maintained for 24 hr. The following day, cells were split and seeded onto 12-well culture dishes (one transfected plate per 12-well dish) for cAM P assays as well as onto 12-well plates (two wells per transfection) for ␤-galactosidase assays (see below). The next morning, cells used for cAM P assays were labeled for 4 -6 hr with 2-3 Ci of [ 3 H]adenine (IC N) per well. Just before the cAM P assay, companion cells for the ␤-galactosidase assays were lysed and harvested in 500 l of buffer B (100 mM KH 2 PO 4 , pH 7.8, 0.2% Triton X-100, and 1 mM DTT) and frozen until use. cAM P and ␤-galactosidase assays were performed as described, and all data were normalized to the measured ␤-galactosidase signal for each transfection.
␤-Galactosidase assay. Lysates from transiently transfected cells were thawed and centrif uged at 16,000 ϫ g for 10 min. The supernatant (20 l) was combined with 100 l of reaction buffer [100 mM Na 2 HPO 4 , pH 8.0, 1 mM MgC l 2 , 35 mM Galacton (Tropix, Bedford, M A), and 100 mM D-galactose] and incubated in the dark at room temperature for 60 min. During the incubation period, a 10% solution of Emerald (Tropix) in 0.2N NaOH was prepared for subsequent addition to the samples at 5 sec intervals by a Berthold luminometer. Each well of lysed cells was assayed Figure 1 . G s -coupled receptors stimulate AC4 in H EK 293 cells. A, H EK 293 cells stably expressing AC4 were treated with increasing concentrations of isoproterenol. B, H EK 293 cells stably coexpressing AC4 with the G s -coupled 5-HT 7 receptor were treated with increasing concentrations of serotonin. Relative cAM P accumulation was determined as described in Materials and Methods, and endogenous HEK 293 cell cAM P accumulation was subtracted from the cAM P measured in AC4-expressing cells. The data are the means Ϯ SD of triplicate assays.
in duplicate, and the data were used to normalize for transfection efficiency.
Description of AC2 and AC4 antibodies. The anti-AC2 and -AC4 antibodies generated by Santa Cruz Biotechnology are rabbit polyclonal antibodies generated against 20 amino acid peptides corresponding to unique intracellular C -terminal amino acid sequences in AC2 and AC4, respectively. The sequence used to generate the AC2 antibody corresponds to amino acids 1071-1090 (K TYFV N TEMSRSL SQSN L AS) of rat AC2, which is 95% identical to the corresponding human sequence. The sequence used to generate the AC4 antibody corresponds to amino acids 1045-1064 (QLC TYFL N TDLTRTGSPSAS) of rat AC4. Database searches using GCG Blast revealed high-score matches only to rat and human AC2 for the AC2 antigen peptide and to rat AC4 for the AC4 antigen peptide.
Western blot anal ysis of AC2 and AC4 e xpression in HEK 293 cells. HEK 293 cells expressing the pCEP4 vector alone or cells stably transfected with AC2 or AC4 were grown to confluence in 100 mm culture dishes and harvested in 20 mM Tris HC l, pH 7.4, 1 mM EDTA, 2 mM MgC l 2 , 0.5 mM DTT, 0.5 mM PMSF, 3.2 g /ml leupeptin, 2 g /ml aprotinin, and 0.5 g /ml pepstatin A. Homogenates were centrif uged at 600 ϫ g for 5 min, and the supernatant was retained and centrif uged at 90,000 ϫ g for 30 min. Membrane pellets were resuspended in buffer C (1% N P-40, 50 mM sodium phosphate, pH 7.4, 10 mM EDTA, 1 mM DTT, 2 mM MgC l 2 , 0.5 Figure 2 . Pertussis toxin, ␤ARK 1 PH domain peptide expression, and transducin ␣ (G t ) expression block G i -coupled receptor potentiation of G s -stimulated AC4. A, H EK 293 cells stably expressing AC4 were incubated overnight with vehicle (ϪPTx) or 200 ng /ml pertussis toxin (ϩPTx). The following day, cells were treated with vehicle or 10 M isoproterenol (iso) in the presence or absence of 500 nM somatostatin (som). Relative cAMP accumulation was determined as described in Materials and Methods. The data are the means Ϯ SD of triplicate assays. B, H EK 293 cells were transiently transfected with RSV-␤-galactosidase and the 5-HT 7A receptor, along with either pCDNAIII or the ␤ARK 1 PH domain and either pCEP4 or pCEP4-AC4 as described in Materials and Methods. Cells transfected with the ␤ARK 1 PH domain are denoted PH domain. AC4-transfected cells with or without the PH domain were treated with 10 M serotonin in the presence or absence of 500 nM somatostatin. 5-HTstimulated activity did not differ significantly between AC4-transfected and AC4-and PH domain-transfected cells; the ratio value for AC4 cells in response to 5-HT alone was 2.088 Ϯ 0.389 and for AC4 and PH domain cells was 3.565 Ϯ 0.688. C, C ells were transiently transfected with RSV-␤-galactosidase and the 5-HT 7A receptor, along with either pCDNAIII or transducin ␣ and either pCEP4 or pCEP4-AC4 as described in Materials and Methods. Cells transfected with transducin ␣ are denoted Gt. C ells were treated with 1 M serotonin in the presence or absence of 500 nM somatostatin. 5-HT-stimulated activity did not differ significantly between AC4-transfected and AC4-and Gt-transfected cells; the ratio value for AC4 cells in response to 5-HT alone was 0.630 Ϯ 0.292 and for AC4 and Gt cells was 0.622 Ϯ 0.091. For B and C, relative cAM P accumulation was determined as described in Materials and Methods. The data are expressed as percent cAMP accumulation in the absence of somatostatin, with this level being set as 100%. The fold stimulation over the basal (293) or AC2-pCEP4 (293-AC2) was subjected to native PAGE conditions and Western blotted as described in Materials and Methods. Blots were developed using enhanced chemiluminescence and scanned on a Hewlett-Packard Scan Jet II C X scanner. B, Membranes from H EK 293 cells were prepared and treated with or without N-glycosidase F as described in Materials and Methods. Twenty micrograms of membranes from 293-pCEP4 cells (293; lanes 1 and 2) and 293-AC4 cells (293-AC4; lanes 3 and 4 ) were separated by SDS-PAGE on 7.5% acrylamide gels. Protein was transferred to nitrocellulose and incubated with anti-AC4 antibody. Molecular weight markers equal 206, 117, 89, and 47 kDa. Note the conversion of the glycosylated form(s) to the lower molecular weight nonglycosylated form after treatment with N-glycosidase F. A minor band at ϳ60 kDa is only seen in AC4-expressing cells and is therefore probably a proteolytic fragment of AC4 that is recognized by the AC4 antibody.
4 activity was similar between transfections with or without the PH domain or transducin ␣. The data are the means Ϯ SD of triplicate assays and were subtracted for endogenous (pCEP4-transfectant) cAMP accumulation and corrected for transfection efficiency using ␤-galactosidase. mM PMSF, 5 g /ml leupeptin, and 2 g /ml aprotinin) and were used immediately or frozen at Ϫ80°C for later use. Protein concentrations were determined according to the method of Bradford, using BSA as a standard (Bradford, 1976) . Some AC4 samples were subjected to deglycosylation by N-glycosidase F (Boehringer Mannheim, Indianapolis, I N) before electrophoresis. T wenty microgram samples were resuspended in buffer C, SDS was added to 0.1%, and samples were heated at 95°C for 5 min. Samples were deglycosylated with 0.5 units of N-glycosidase F for 1 hr at 37°C. The deglycosylation reaction was terminated by addition of Laemmli buffer (Laemmli, 1970) . Proteins were separated by native PAGE (for AC2) or SDS-PAGE (for AC4) on 7.5% acrylamide gels and were subsequently transferred to a poly vinylidene difluoride membrane (AC2) or nitrocellulose (AC4) and blocked with 3% cold fish gelatin (Sigma) in 20 mM Tris HC l, pH 7.4, 150 mM NaC l, and 0.05% T ween 20 for 1-2 hr at room temperature. Blots were incubated with 100 ng /ml anti-AC2 or -AC4 at 4°C for 16 -20 hr followed by HRP-conjugated goat anti-rabbit IgG for 1 hr. Blots were developed by enhanced chemiluminescence (Amersham, Arlington Heights, IL) according to the manufacturer's guidelines.
HEK 293 cell immunoc ytochemistr y. H EK 293 cells alone or stably transfected with AC2 or AC4 were plated onto poly-D-lysine-coated coverslips (60 g /ml poly-D-lysine) and grown in appropriate growth medium for 2-4 d. C ells were fixed with 4% paraformaldehyde in PBS, pH 7.4, for 20 min, rinsed with PBS, and permeabilized and blocked for 1 hr with PBS plus 0.5% Triton X-100, 4% cold fish gelatin, and 1% normal goat serum. C ells were incubated with 100 ng /ml anti-AC2 or -AC4 in PBS plus 0.5% cold fish gelatin overnight at 4°C on a rocker, rinsed, and then incubated with 1 g /ml lissamine-rhodamineconjugated goat anti-rabbit IgG for 1 hr. After a final rinse, the coverslips were mounted onto slides with Gelmount (Biomedia, Foster C ity, CA). Where indicated, peptide antigen specific for AC2 or AC4 (Santa Cruz Biotechnology) was included at a 20-fold molar excess to antibody as a control.
Immunohistochemistr y on mouse hippocampal sections. C57Bl /6J mice were killed by decapitation, and the brains were quickly removed. Coronal brain slices (500 m) were cut using a vibratome (C ampden Instruments, Leicestershire, UK). Slices were fixed for 4 -6 hr with 4% para- formaldehyde in PBS, pH 7.4. After fixation, slices were cryoprotected in PBS plus 30% sucrose and 0.02% NaN 3 and were maintained at 4°C until f urther use. For immunolabeling, 40 m sections were cut from the fixed 500 m slices on a sliding microtome and placed free-floating into a blocking solution of PBS, pH 7.4, plus 0.025% Triton X-100 (PBST) supplemented with 5% BSA. Sections were blocked for 1 hr at room temperature and then incubated in PBST plus 0.5% BSA and 250 or 125 ng /ml rabbit polyclonal antibody against AC2 or AC4, respectively, for 18 -24 hr. Where indicated, peptide antigens were added at a 20-fold molar excess to antibody immediately before incubation. After incubation with the primary antibody, sections were washed four times for 10 min in PBST at room temperature, after which 1 g /ml lissaminerhodamine-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA) was added to the sections for 1 hr at room temperature. Sections were then washed and mounted onto slides using Gelmount (Biomedia) or Vectashield (Vector Laboratories, Burlingame, CA). For double labeling, a 1 hr incubation in a 1:400 dilution of mouse monoclonal anti-synaptophysin (clone SV P-38, ascites fluid; Sigma) or a 1:500 dilution of mouse monoclonal anti-M AP2 (clone HM-2, ascites fluid; Sigma) was followed by incubation in 1 g /ml FI TC -conjugated goat anti-mouse antibody (Jackson ImmunoResearch). Immunolabeling was analyzed using a Bio-Rad MRC 600 confocal microscope (William M. Keck Imaging C enter, University of Washington, Seattle, WA). Labeling of discrete brain structures was determined according to the mouse brain atlas of Franklin and Paxinos (1997) . Images were processed using Adobe Photoshop 4.0.
RESULTS

G-protein-coupled receptors stimulate AC4 in intact cells
HEK 293 cells were transfected with AC4 cDNA, and cells from the stably selected polyclonal cell line were treated with the ␤-adrenergic agonist isoproterenol. H EK 293 cells express endogenous ␤-adrenergic receptors that couple to stimulation of adenylyl cyclase via G s Wayman et al., 1994 Wayman et al., , 1995 . Isoproterenol increased cAM P with an EC 50 value of ϳ200 nM. Maximal stimulation occurred at 1 M (Fig. 1 A) . The sharp isoproterenol dose -response curve may reflect isoproterenol oxidation, yielding a threshold effect at 1 M isoproterenol. cAMP was also measured in response to serotonin in 293-AC4 cells stably coexpressing the G s -coupled 5-HT 7A receptor (Shen et al., 1993) . cAM P accumulation in nontransfected cells was subtracted from the 293-AC4 value. Serotonin increased cAMP with an EC 50 value of ϳ8 nM and with maximal stimulation at 250 nM serotonin (Fig. 1 B) . The extended dose -response curve for 5-HT was observed consistently and may be attributable to differential properties of overexpressed transfected (5-HT 7A ) versus endogenous (␤-adrenergic) receptors. These data demonstrate that AC4 is stimulated by activation of G s -coupled receptors in vivo.
G i -mediated potentiation is inhibited by pertussis toxin and by ␤␥-binding peptides
G-protein ␤␥ subunits potentiate G s␣ stimulation of AC2 and AC4 (Gao and Gilman, 1991) in vitro. To determine whether G i stimulates AC4 in vivo, we treated HEK 293 cells expressing AC4 with somatostatin in the presence or absence of pertussis toxin. Endogenous somatostatin receptors expressed in HEK 293 cells activate G i and inhibit adenylyl cyclases (Nielsen et al., 1996) . Pertussis toxin catalyzes the ADPribosylation of the G i /G o class of G-proteins (Katada and Ui, 1982; Burns et al., 1983; Hsia et al., 1984; Neer et al., 1984) leading to uncoupling of the receptor and G i (West et al., 1985) . Recognition of the heterotrimer and ADP-ribosylation of the ␣ subunit prevent the subsequent release of the ␤␥ subunit (for review, see Gierschik, 1992 ). In cells not treated with pertussis toxin, isoproterenol stimulated AC4 threefold. Somatostatin alone induced a slight inhibition of basal activity and did not stimulate AC4. However, coapplication of isoproterenol and somatostatin produced a synergistic increase in cAMP over that observed in response to isoproterenol alone (Fig. 2 A) . Pertussis toxin treatment increased basal activity, and the somatostatin potentiation of isoproterenol-stimulated cAMP was completely blocked (Fig. 2 A) . These results indicate that somatostatin enhancement of AC4 activation is caused by G i .
To determine whether somatostatin increases AC4 activity by stimulating the release of ␤␥ from G i , we performed transient transfections of HEK 293 cells in which the G s -coupled 5-HT 7A receptor and AC4 were cotransfected with a construct encoding the ␤␥-binding, C-terminal region of ␤-adrenergic receptor kinase 1 (referred to here as the pleckstrin homology or PH domain). Cellular expression of this PH domain can attenuate the effect of ␤␥ on the MAP kinase pathway and phospholipase C Koch et al., 1994; Luttrell et al., 1995) . In cells transfected with 5-HT 7A , AC4, and the empty vector for the PH domain, somatostatin potentiated serotonin stimulation of AC4 by ϳ80% (Fig. 2 B) . When the PH domain was coexpressed, somatostatin potentiation of G s -stimulated AC4 was completely abolished (Fig. 2 B) . Similar results were obtained using a cotransfected using a cotransfected transducin ␣ subunit as a ␤␥ scavenger. Coexpression of transducin ␣ (G t ) with AC4 and the 5-HT 7A receptor inhibited somatostatin-mediated potentiation of serotonin-induced cAMP levels (Fig. 2C) . These data suggest that somatostatin stimulation of G s -activated AC4 activity is caused by ␤␥ release from G i .
Characterization of AC2 and AC4 antibodies in HEK 293 cells
Before determining the expression of AC2 and AC4 in the hippocampus, we characterized the specificity of the AC2 and AC4 polyclonal antibodies by Western blot and immunolabeling studies. By Western blot, the AC2 antibody recognized AC2 overexpressed in HEK 293 cells under native conditions and very little under denaturing conditions (Fig. 3A) . HEK 293 cells express low levels of AC2 endogenously (Hellevuo et al., 1993) . Accordingly the AC2 antibody also recognized a low level of AC2 in nontransfected cells (Fig. 3A) . The specificity of the AC4 antibody was also analyzed by Western blot (Fig. 3B) . Untransfected H EK 293 cells showed no immunoreactive bands, whereas cells overexpressing AC4 showed bands at ϳ110 and 150 kDa. Treatment with N-glycosidase F shifted the 150 kDa band to the lower molecular weight, indicating that the lower band corresponds to non-or subglycosylated AC4. A minor band detected at ϳ60 kDa was observed in AC4-expressing cells only and is likely a proteolytic fragment of AC4 that is also recognized by the AC4 antibody.
Immunolabeling studies using untransfected H EK 293 cells or cells expressing AC2 or AC4 were also performed (Fig. 4) . The AC2 antibody produced a low level of labeling in H EK 293 cells transfected with the empty expression vector (Fig. 4 A) . In contrast, pronounced membrane labeling was observed in cells stably expressing AC2 (Fig. 4 B) , which was completely abrogated after AC2 peptide adsorption (Fig. 4C) . No AC2 labeling over endogenous levels was observed in AC4-expressing cells (Fig. 4 D) . Similarly, the AC4 antibody labeled cells expressing AC4 (Fig.  4 F) but not vector-transfected cells (Fig. 4 E) or cells expressing AC2 (Fig. 4 H) . Adsorption of the AC4 antibody with the AC4 peptide blocked all immunolabeling with the AC4 antibody (Fig.  4G) . The AC2 and AC4 antibodies also did not recognize other adenylyl cyclases (AC1, AC3, AC5, AC6, AC8, and AC9) expressed in H EK 293 cells (data not shown).
Analysis of AC2 and AC4 expression in mouse hippocampal formation
To define the expression and localization of AC2 and AC4 proteins in the mouse hippocampal formation, we performed immunhistochemical studies. The AC4 antibody was also used to immunoprecipitate AC4 from mouse hippocampal membranes (data not shown). The AC2 antibody was not usef ul for immunoprecipitation. For immunohistochemistry, 40 m hippocampal slices were labeled using either the AC2 or AC4 antibody and were examined by confocal microscopy. Specific labeling for both adenylyl cyclase isoforms was observed throughout the hippocampal formation, and the labeling pattern was more or less indistinguishable for both AC2 and AC4. In the dentate gyrus, immunolabeling for AC2 and AC4 was concentrated in the proximal dendrites of the granule cells and extended into the dendritic field in the molecular layer (Fig. 5 A, B) . A lower level of labeling was also observed in the cell bodies. Double labeling was performed for AC2 or AC4 and either a dendritic marker (M AP2; Figs. 6, 7) or a synaptic terminal marker (synaptophysin; Figs. 8, 9 ). AC signal was coincident with the M AP2 labeling in the dendrites (Fig. 6C, F, CЈ,FЈ ; yellow indicates coincident signal) and did not colocalize at all with the synaptophysin signal (Fig. 8) , indicating a postsynaptic localization of these adenylyl cyclase isoforms. Scattered cells in the hilus were also labeled using the AC2 and AC4 antibodies.
In area CA3, labeling for both AC2 and AC4 was concentrated in short, coronally sectioned CA3 pyramidal cell dendrites throughout the stratum lucidum (Fig. 5C,D) . Upon closer examination, the labeling was coincident with MAP2 signal (Fig.  10C, F, CЈ,FЈ) . Similar to the pattern observed in the dentate gyrus, the labeling pattern was not colocalized with synaptophysin signal (Fig. 11C, F, CЈ,FЈ) . In fact, the adenylyl cyclase label appeared in many instances to be surrounded by synaptophysin labeling, similar to what has been described (Lim et al., 1997) where several mossy fiber synaptic terminals or a single large terminal impinge on a given dendritic region. There was very little labeling for AC2 or AC4 in the CA3 pyramidal cell bodies. In area CA1, immunofluorescence for both AC2 and AC4 was concentrated along the apical dendrites throughout the stratum radiatum, with some labeling in the CA1 pyramidal cell bodies as well (Fig. 5 E, F ) . As with the labeling in the dentate gyrus and CA3, the signal was coincident with the signal for the postsynaptic marker MAP2 (Fig. 7C, F, CЈ,FЈ) and was not colocalized with labeling for synaptophysin (Fig. 9) . Very little labeling was seen in the processes in the stratum oriens, although occasional small cell bodies did label for AC2 or AC4. The labeling for AC2 and AC4 throughout the hippocampal formation was completely blocked by adsorption with the appropriate peptide antigen (Figs. 8C,F, 9C,F ). Double labeling for AC2 and AC4 in the same tissue sections using a combination of fluorophore-labeled IgG and Fab fragments demonstrated that AC2 and AC4 are expressed in a very similar manner in the mouse hippocampal formation (data not shown). The only consistent difference in labeling was a slightly higher level of AC2 over AC4 signal in the dentate gyrus granule somas (Fig. 5 A, B) .
Immunohistochemical labeling for AC4 was also observed in several forebrain regions. In the neocortex and piriform cortex, a moderate percentage of neurons were labeled and included pyramidal cell bodies and dendrites (data not shown). Discrete labeling of neurons in the septum, medial habenular nucleus, induseum griseum, and the paraventricular thalamic nucleus was also seen (data not shown).
DISCUSSION
Each of the adenylyl cyclase isoforms possesses distinct regulatory properties, and all of the cloned mammalian adenylyl cyclases are expressed in the brain. Therefore, cAMP levels in neurons can be modulated by a variety of signals, including receptor activation, changes in intracellular Ca 2ϩ , and activation of protein kinases (for review, see Sunahara et al., 1996) . Of particular interest are adenylyl cyclases that integrate coincident signals from different upstream pathways. For example, AC1 is synergistically stimulated by G s -coupled receptors and Ca 2ϩ Wayman et al., 1994) and contributes to mossy fiber-CA3 LTP (Villacres et al., 1998) . Other examples include the ␤␥-stimulated adenylyl cyclases, which are synergistically activated by G s -coupled receptors and ␤␥ released from G i -coupled receptors.
Whereas most mammalian tissues express adenylyl cyclase activity that is inhibited by activation of G i -coupled receptors, in the brain and lung, G i -coupled receptors actually potentiate G sstimulated cAM P production (Andrade, 1993; Gereau and Conn, 1994; Pian and Dobbs, 1995; Olianas et al., 1998) . In the hippocampus, in particular, several groups have observed potentiation of G s -coupled receptor stimulation by G i -coupled receptors (Andrade, 1993; Gereau and Conn, 1994) . The C a 2ϩ -stimulated adenylyl cyclases (AC1 and AC8) are thought to play a role in synaptic plasticity in the hippocampus (Choi et al., 1993; Weisskopf et al., 1994; Wu et al., 1995; X ia et al., 1995; Villacres et al., 1998) . However, the detection of mRNA in the hippocampus for at least one ␤␥-stimulated adenylyl cyclase, AC2 (Furuyama et al., 1993) , suggests that there may be additional mechanisms for generating the robust cAM P increases thought to underlie synaptic plasticity. The goals of this research were to determine whether AC4 is stimulated by ␤␥ subunits in intact cells and to determine the expression and localization of AC2 and AC4 in the hippocampus.
In this study, we demonstrated that AC4 is stimulated by G s -coupled receptors in intact H EK 293 cells. This is consistent with previous in vitro data (Gao and Gilman, 1991) and recent work by Avidor-Reiss et al. (1997) using C OS-7 cells that demonstrated that AC4 is stimulated by recombinant or endogenous G s␣ , respectively. Additionally, we found that G i -coupled receptor activation potentiates the response of AC4 to G s -coupled receptors in vivo. Specifically, stimulation of AC4 by G s -coupled receptors was potentiated by activation of G i -coupled somatostatin receptors. Somatostatin potentiation of isoproterenolstimulated AC4 was blocked by pertussis toxin. In addition, in transient transfection experiments, coexpression of the C-terminal, ␤␥-binding region of ␤ARK 1 (PH domain) or transducin ␣ (G t ) effectively blocked somatostatin potentiation of 5-HT 7A -stimulated AC4 activity. This indicates that AC4 responds to paired G s and G i inputs in vivo with ␤␥ potentiation. Similar findings have been observed for AC2 in vivo (Federman et al., 1992; L ustig et al., 1993; Koch et al., 1994 ). These results demonstrate that both AC2 and AC4 can f unction as coincidence detectors of paired G s and G i inputs. It has also been demonstrated that AC2 can detect simultaneous activation of PKC and G i (Tsu and Wong, 1996) . It is possible that ␤␥ potentiation of AC2 could also occur via ␤␥ activation of phospholipase C (Banno et al., 1998) , which then results in the activation of perhaps another PKC isoform. This would not be expected to occur with AC4 because AC4 has been demonstrated to be insensitive to PKC (Jacobowitz et al., 1993) . Because coincidence detection of separate, temporally overlapping signals is believed to be important for neuroplasticity (Bourne and Nicoll, 1993) , our results suggest a role for AC4 in addition to AC2 in synaptic plasticity.
A second aspect of this study was directed at elucidating immunohistochemically the localization of AC2 and AC4 in the mouse hippocampal formation. To this end, we demonstrated that both AC2 and AC4 proteins are expressed in the hippocampus. The immunohistochemical labeling pattern for both AC2 and AC4 was for the most part indistinguishable and colocalized with that for M AP2, a dendritic and /or postsynaptic marker, in all regions of the hippocampal formation. In the dentate gyrus, labeling was found in the proximal dendrites and extended into the dendritic field in the molecular layer. In CA3, AC2 and AC4 immunolabeling was concentrated in the CA3 pyramidal cell dendrites throughout the stratum lucidum. In the CA1 region, AC2 and AC4 labeling was concentrated along the apical dendrites of the pyramidal cells and extended throughout the stratum radiatum. This postsynaptic pattern is similar to that described by Mons et al. (1995) using an antibody generated against a common domain in all adenylyl cyclase isoforms. At least at this level of resolution and compared with the labeling pattern for synaptophysin, AC2 and AC4 are not expressed presynaptically in the hippocampus. These results are the first to demonstrate the localization of AC2 and AC4 proteins in the hippocampus. Double labeling with markers for pre-and postsynaptic sites (synaptophysin and MAP2, respectively) strongly indicate that both AC2 and AC4 are localized postsynaptically along the dendrites in all regions of the hippocampus.
Possible roles for ␤␥-stimulated adenylyl cyclases in synaptic plasticity are as follows. AC2 may serve to integrate inputs from multiple signaling pathways, because it can respond to either G s␣ or PKC and ␤␥ from G i with potentiation in vivo (Federman et al., 1992; Lustig et al., 1993; Tsu and Wong, 1996) . Additionally, PKC may suppress the responsiveness of AC2 to paired G s␣ and ␤␥ stimulation (Zimmermann and Taussig, 1996) . These regulatory features may allow for the generation of cAMP signals with the necessary spatial and temporal characteristics to contribute to long-term changes in synaptic strength (Backsai et al., 1993) . Consistent with this notion, mossy fiber-CA3 LTP has been reported to be dependent on activation of G i /G o -coupled opioid receptors (Williams and Johnston, 1996) and pertussis toxinsensitive G-proteins (Ito et al., 1988) . We have focused on ␤␥ subunits released from G i . However, it is possible that ␤␥ subunits released from G q or other pertussis toxin-insensitive G-proteins could facilitate potentiated adenylyl cyclase activity in vivo, as has been postulated to occur in the frontal cortex .
A possible role for AC4 in synaptic plasticity in the hippocampus may be to integrate G s and G i inputs, perhaps as a complement to the signal generated by AC2. The presence of AC2 and AC4 in the hippocampus thus allows for flexibility in the generation of robust cAMP increases necessary for synaptic plasticity. In addition to relying on the Ca 2ϩ -stimulated adenylyl cyclases as a means of eliciting cAMP-mediated long-term adaptive changes, hippocampal neurons may have evolved with several distinct mechanisms for expression of synaptic plasticity. It is possible that there exist two (or more) parallel pathways involving cAMP that encode different forms of synaptic plasticity. With respect to the AC4 immunolabeling observed in the forebrain, it is intriguing that several of these areas are sites in which synaptic plasticity has been demonstrated (e.g., neocortex and piriform cortex) (Hasselmo and Barkai, 1995; Cruikshank and Weinberger, 1996) .
In summary, these results demonstrate that AC4 can act as a coincidence detector of paired G s and G i inputs. The finding that both AC2 and AC4 proteins are expressed postsynaptically in hippocampus suggests that these adenylyl cyclase isoforms may play a role in certain forms of hippocampal synaptic plasticity.
